Severe liver and skin toxicity after radiation and vemurafenib in metastatic melanoma

Journal of Clinical Oncology

Volumn 31, Issue 17, 2013, Pages

  Anker, Christopher J ^a   Ribas, Antoni ^b   Grossmann, Allie H ^c   Chen, Xinjian ^c   Narra, Krishna K ^c   Akerley, Wallace ^a   Andtbacka, Robert H I ^a   Noyes, Robert Dirk ^d   Shrieve, Dennis C ^a   Grossmann, Kenneth F ^a  

^a UNIVERSITY OF UTAH   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF UTAH   (United States)

^d INTERMOUNTAIN HEALTHCARE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B RAF KINASE; VEMURAFENIB;

ADOLESCENT; ALOPECIA; ARTICLE; AUTOPSY; BACKACHE; BONE METASTASIS; BRAIN METASTASIS; CANCER CHEMOTHERAPY; CANCER GROWTH; CANCER MORTALITY; CANCER RADIOTHERAPY; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; DRUG WITHDRAWAL; ERYTHEMA; FEMALE; FOLLOW UP; GENE MUTATION; HUMAN; LIVER TOXICITY; METASTATIC MELANOMA; MULTIMODALITY CANCER THERAPY; NUCLEAR MAGNETIC RESONANCE IMAGING; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; RASH; SKIN TOXICITY; SPLEEN METASTASIS; STEREOTACTIC RADIOSURGERY; THORAX PAIN;

ADOLESCENT; ANTINEOPLASTIC AGENTS; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INDOLES; LYMPH NODE EXCISION; MELANOMA; NEOPLASM METASTASIS; RADIATION INJURIES; SKIN DISEASES; SKIN NEOPLASMS; SULFONAMIDES;

EID: 84886635164     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2012.44.7755     Document Type: Article

References (17)

1. Flaherty KT, Puzanov I, Kim KB, et al: Inhibition of mutated, activated BRAF in metastatic melanoma. N Engl J Med 363:809-819, 2010
2. Rofstad EK, Brustad T: Broad-shouldered survival curves of a human melanoma xenograft: Implications for radiation therapy in the absence and presence of misonidazole. Acta Radiol Oncol 20:261-265, 1981
3. Overgaard J, von der Maase H, Overgaard M: A randomized study comparing two high-dose per fraction radiation schedules in recurrent or metastatic malignant melanoma. Int J Radiat Oncol Biol Phys 11:1837-1839, 1985
4. Sause WT, Cooper JS, Rush S, et al: Fraction size in external beam radiation therapy in the treatment of melanoma. Int J Radiat Oncol Biol Phys 20:429-432, 1991
5. Seegenschmiedt MH, Keilholz L, Altendorf-Hofmann A, et al: Palliative radiotherapy for recurrent and metastatic malignant melanoma: Prognostic factors for tumor response and long-term outcome - A 20-year experience. Int J Radiat Oncol Biol Phys 44:607-618, 1999
6. Konefal JB, Emami B, Pilepich MV: Analysis of dose fractionation in the palliation of metastases from malignant melanoma. Cancer 61:243-246, 1988
7. Susser WS, Whitaker-Worth DL, Grant-Kels JM: Mucocutaneous reactions to chemotherapy. J Am Acad Dermatol 40:367-398, 1999
8. Sambade MJ, Peters EC, Thomas NE, et al: Melanoma cells show a heterogeneous range of sensitivity to ionizing radiation and are radiosensitized by inhibition of B-RAF with PLX-4032. Radiother Oncol 98:394-399, 2011
9. Chung EJ, Brown AP, Asano H, et al: In vitro and in vivo radiosensitization with AZD6244 (ARRY-142886), an inhibitor of mitogen-activated protein kinase/extracellular signal-regulated kinase 1/2 kinase. Clin Cancer Res 15:3050-3057, 2009
10. Donaldson SS, Glick JM, Wilbur JR: Letter: Adriamycin activating a recall phenomenon after radiation therapy. Ann Intern Med 81:407-408, 1974
11. Howard R: Actinomycin D in Wilm's tumour: Treatment of lung metastases. Arch Dis Child 40:200-202, 1965
12. Tefft M, Mitus A, Jaffe N: Irradiation of the liver in children: Acute effects enhanced by concomitant chemotherapeutic administration? Am J Roentgenol Radium Ther Nucl Med 111:165-173, 1971
13. Ludwig R, Weirich A, Abel U, et al: Hepatotoxicity in patients treated according to the nephroblastoma trial and study SIOP-9/GPOH. Med Pediatr Oncol 33:462-469, 1999
14. Abadir R, Liebmann J: Radiation reaction recall following simvastatin therapy: A new observation. Clin Oncol (R Coll Radiol) 7:325-326, 1995
15. Fakih MG: Gemcitabine-induced rectus abdominus radiation recall. JOP 7:306-310, 2006
16. Hird AE, Wilson J, Symons S, et al: Radiation recall dermatitis: Case report and review of the literature. Curr Oncol 15:53-62, 2008
17. Feng M, Smith DE, Normolle DP, et al: A phase I clinical and pharmacology study using amifostine as a radioprotector in dose-escalated whole liver radiation therapy. Int J Radiat Oncol Biol Phys 83:1441-1447, 2012